Assessment of disease activity control and evaluation strategy in patients with Takayasu arteritis undergoing cardiac surgery: a retrospective cohort study - Report - MDSpire

Assessment of disease activity control and evaluation strategy in patients with Takayasu arteritis undergoing cardiac surgery: a retrospective cohort study

  • By

  • XinPei Liu

  • Di Wu

  • Jun Zheng

  • ChaoJi Zhang

  • ShangDong Xu

  • XingRong Liu

  • GuoTao Ma

  • Sheng Yang

  • JianZhou Liu

  • Qi Miao

  • June 3, 2026

  • 0 min

Share

Clinical Report: Evaluation of Disease Activity Management in Takayasu Arteritis

Overview

This study evaluates the clinical safety of a multidisciplinary approach for managing Takayasu's arteritis (TAK) patients undergoing cardiac surgery. It highlights the increased risk of surgical site complications and long-term cardiovascular events in the TAK cohort compared to matched controls.

Background

Takayasu's arteritis is a large-vessel vasculitis that can lead to significant cardiovascular complications, necessitating surgical interventions. Patients with TAK are at an increased risk of perioperative complications due to systemic inflammation and corticosteroid therapy. Understanding the impact of a structured preoperative management strategy is crucial for improving surgical outcomes in this population.

Data Highlights

OutcomeTAK CohortNTAK CohortP-value
Surgical site complications17.19%0%0.003
Cardiovascular re-hospitalization (sHR)3.487-0.007
New cardiovascular surgery (sHR)6.342-0.021
Risk of structural reoperation (sHR)1.077-0.941

Key Findings

  • The TAK cohort had a higher incidence of surgical site complications compared to NTAK controls (17.19% vs. 0%, P = 0.003).
  • There was no significant difference in early postoperative mortality/complication rates between TAK and NTAK cohorts.
  • TAK patients experienced a significantly higher incidence of cardiovascular re-hospitalization (sHR: 3.487; P = 0.007).
  • New cardiovascular surgeries were more common in the TAK group (sHR: 6.342; P = 0.021).
  • The risk of structural reoperation due to initial surgical failure did not differ significantly between cohorts (sHR: 1.077; P = 0.941).

Clinical Implications

The findings suggest that while a multidisciplinary approach can mitigate some risks associated with cardiac surgery in TAK patients, there remains a heightened long-term risk for cardiovascular events. Clinicians should be aware of these risks when managing TAK patients pre- and postoperatively.

Conclusion

This study demonstrates that a structured multidisciplinary strategy for managing TAK patients undergoing cardiac surgery does not increase mortality or major complications but highlights the need for ongoing monitoring of cardiovascular risks.

Related Resources & Content

  1. Clinical Rheumatology, 2025 -- Enhancing Ultrasound Assessment of Carotid Artery Stenosis in Takayasu's Arteritis: Emphasizing Residual Inner Diameter as a Critical Metric
  2. Clinical Research in Cardiology, 2025 -- Cardiovascular Complications in Individuals with Vasculitis
  3. Clinical Research in Cardiology, 2025 -- Assessment of Left Ventriculo-Arterial Coupling in Patients with Wild-Type Transthyretin Cardiac Amyloidosis Receiving Tafamidis Treatment
  4. Clinical Research in Cardiology, 2025 -- Evaluating the RAISE Score in Postoperative Outcomes of Cardiac Transthyretin Amyloidosis Following Aortic Valve Replacement
  5. JCS 2026 Guideline on Management of Large Vessel Vasculitis
  6. 2026 Japanese Circulation Society Guideline
  7. REVIEW Circulation Journal Circ J  2025; 89: 1849

Original Source(s)

Related Content